Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>Baseline characteristics, biochemical laboratory parameters, comorbidities, and classification of...
<p>Baseline clinical and biochemical characteristics of the study subjects according to baseline met...
Clinical parameters of the two study groups at the baseline and during follow-up.</p
<p>Clinical and biochemical parameters for both the overall population and the Survivors and non-Sur...
<p>Baseline characteristics and biochemical parameters of LC and HCC patients.</p
<p>Baseline clinical, anthropometric, and biochemical characteristics of the study populations.</p
<p>Biochemical parameters of 23 C1-INH-HAE patients and 24 controls (rest and tilt).</p
<p>Baseline biochemical characteristics of enrolled patients, evaluated by per protocol analysis.</p
<p>Baseline clinical hematological and biochemical parameters, parameters, SOFA score, and immune pr...
<p>Baseline clinical and biochemical characteristics of hospitalized patients with acute HF stratifi...
<p>Clinical and biochemical parameters for the healthy, WDM-NP, DM-WNP, and DM-NP subjects.</p
<p>Values are mean± SD;</p>#<p>p = 0.003 High Hcy vs Low Hcy at baseline;</p><p>*p<0.001 High Hcy vs...
Treatment parameters of the two study groups at the baseline and during follow-up period.</p
Laboratory baseline and follow up parameters (n = 1158 for hemoglobin at admission, n = 939 for hemo...
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>Baseline characteristics, biochemical laboratory parameters, comorbidities, and classification of...
<p>Baseline clinical and biochemical characteristics of the study subjects according to baseline met...
Clinical parameters of the two study groups at the baseline and during follow-up.</p
<p>Clinical and biochemical parameters for both the overall population and the Survivors and non-Sur...
<p>Baseline characteristics and biochemical parameters of LC and HCC patients.</p
<p>Baseline clinical, anthropometric, and biochemical characteristics of the study populations.</p
<p>Biochemical parameters of 23 C1-INH-HAE patients and 24 controls (rest and tilt).</p
<p>Baseline biochemical characteristics of enrolled patients, evaluated by per protocol analysis.</p
<p>Baseline clinical hematological and biochemical parameters, parameters, SOFA score, and immune pr...
<p>Baseline clinical and biochemical characteristics of hospitalized patients with acute HF stratifi...
<p>Clinical and biochemical parameters for the healthy, WDM-NP, DM-WNP, and DM-NP subjects.</p
<p>Values are mean± SD;</p>#<p>p = 0.003 High Hcy vs Low Hcy at baseline;</p><p>*p<0.001 High Hcy vs...
Treatment parameters of the two study groups at the baseline and during follow-up period.</p
Laboratory baseline and follow up parameters (n = 1158 for hemoglobin at admission, n = 939 for hemo...
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>Baseline characteristics, biochemical laboratory parameters, comorbidities, and classification of...
<p>Baseline clinical and biochemical characteristics of the study subjects according to baseline met...